South African Medical Research is driving meaningful progress in addressing the region’s most pressing health challenges. What are the priorities of the South African Medical Research Council for shaping the future of health? In a recent interview, President and CEO Ntobeko Ntusi explains how the...

The Portuguese Government has approved the establishment of a national and regional strategic reserve of medicines and medical devices under the Portugal Transformation, Recovery and Resilience (PTRR) plan, involving an investment of 70 million euros. This measure, announced by Prime Minister Luí...

In High-Cost Drug Evaluation, the Dutch Healthcare Institute Zorginstituut Nederland, announced that the average duration for assessing expensive hospital drug...

Amgen financial results for the first quarter of 2026 reveal strong performance. Revenues increased 6% to $8.6 billion. Product sales grew 4%. Volume drove most of this growth. The company generated $1.5 billion in free cash flow (Amgen, 2026). Key Performance...

Rozanolixizumab myasthenia gravis treatment has been recommended by the National Institute for Health and Care Excellence (NICE) as an add-on to standard care for adults with generalised myasthenia gravis (gMG) who are positive for anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosi...

The biotechnology patient access gap in Europe remains a critical challenge despite the continent’s scientific excellence. The EU Biotech Act offers a strategic opportunity to accelerate the delivery of advanced therapies — such as radioligand, cell and gene, and RNA-based treatments — from disco...